Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching Study-Reference-Cited by-同舟云学术

Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching Study

Published:2021-12 Issue: Volume:208 Page:162-169
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Bartoli-Abdou John K.,Patel Jignesh P.,Vadher Bipin,Brown Alison,Roberts Lara N.,Patel Raj K.,Arya Roopen,Auyeung Vivian

Funder

Sanofi

Bayer, United Kingdom

Bayer

Publisher

Elsevier BV

Subject

Hematology

Reference62 articles.

1. Adherence to Long-term Therapies: Evidence for Action;World Health Organisation,2003

2. Adherence to medication;Osterberg;N. Engl. J. Med.,2005

3. Risk factors for nonadherence to warfarin: results from the IN-RANGE study;Platt;Pharmacoepidemiol. Drug Saf.,2008

4. Effect of adherence to Oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation;Yao;J. Am. Heart Assoc.,2016

5. Dabigatran versus warfarin in the treatment of acute venous thromboembolism;Schulman;N. Engl. J. Med.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention;Cerebrovascular Diseases Extra;2024-08-12

2. Medication Adherence to Direct Oral Anticoagulants: Extent and Impact of Side Effects;Patient Preference and Adherence;2024-08

3. Lipid lowering for prevention of venous thromboembolism: a network meta-analysis;European Heart Journal;2024-06-14

4. Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?;Thrombosis and Haemostasis;2024-06-01

5. Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation;Pharmacoepidemiology and Drug Safety;2023-11-27